{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T14:21:33Z","timestamp":1790259693302,"version":"4.1.0"},"reference-count":19,"publisher":"BMJ","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Gut"],"published-print":{"date-parts":[[1992,3]]},"abstract":"<jats:p>Fifteen cases of hepatitis related to a combination of amoxycillin and clavulanic acid are reported. Most patients were aged 60 years or more and there were more men than women (sex ratio 4:1). The amoxycillin-clavulanic acid had been given at doses ranging from 0.5 to 6 g\/day (mean 2 g\/day) for seven to 60 days (mean 18 days). In 11 cases, the first symptoms appeared one to four weeks after stopping treatment. Jaundice was observed in all patients and was frequently associated with pruritus. Serum aminotransferase activities were increased in all patients and were generally two to 10 times the upper limit of normal. Serum alkaline phosphatase activity was considerably increased, from two to seven times the upper limit of normal. Histological examination of the liver, performed in seven patients, showed centri- or panlobular cholestasis in all cases, associated with granulomatous hepatitis in one. The prognosis of amoxycillin-clavulanic acid induced hepatitis seemed to be good. None of the patients exhibited biological or clinical features of hepatic failure and the course of the disease was characterised by the resolution of jaundice within one to eight weeks and a complete recovery within four to 16 weeks. Taking into account the number of treated subjects and reported cases, we estimated the risk of developing hepatitis with this drug combination to be very low, probably below 1\/100,000. Our data suggest that the risk of hepatotoxicity may be increased in elderly men given lengthy treatment. The association of hepatitis and signs of hypersensitivity may suggest an immunoallergic mechanism of hepatotoxicity in some patients.<\/jats:p>","DOI":"10.1136\/gut.33.3.368","type":"journal-article","created":{"date-parts":[[2007,9,18]],"date-time":"2007-09-18T17:41:31Z","timestamp":1190137291000},"page":"368-371","source":"Crossref","is-referenced-by-count":149,"title":["Hepatitis associated with amoxycillin-clavulanic acid combination report of 15 cases."],"prefix":"10.1136","volume":"33","author":[{"given":"D","family":"Larrey","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Vial","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Micaleff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Babany","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Morichau-Beauchant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Michel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J P","family":"Benhamou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[1992,3,1]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1128\/AAC.11.5.852","article-title":"Clavulanic acid: a beta-lactamase inhibiting beta-lactam from streptomyces clavuligerus","volume":"11","author":"Reading, C.; Cole, M.","year":"1977","unstructured":"Reading C, Cole M. Clavulanic acid: a beta-lactamase inhibiting beta-lactam from streptomyces clavuligerus. Antimicrob Agents Chemother 1977; 11: 852-7.","journal-title":"Antimicrob Agents Chemother"},{"key":"ref_2","first-page":"572","article-title":"Kinetics of beta-lactamase inhibition by clavulanic acid","volume":"526","author":"Labia, R.; Peduzzi, J.","year":"1978","unstructured":"Labia R, Peduzzi J. Kinetics of beta-lactamase inhibition by clavulanic acid. Biochem et Biophys Acta 1978; 526: 572-9.","journal-title":"Biochem et Biophys Acta"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1128\/AAC.29.1.107","article-title":"Amoxycillin-clavulanic acid versus cefaclor in the treatment of urinary tract infections and their effects on the urogenital and rectal flora","volume":"29","author":"Iravani, A.; Richard, G.A.","year":"1986","unstructured":"Iravani A, Richard GA. Amoxycillin-clavulanic acid versus cefaclor in the treatment of urinary tract infections and their effects on the urogenital and rectal flora. Antimicrob Agents Chemother 1986; 29: 107-11.","journal-title":"Antimicrob Agents Chemother"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/0016-5085(89)91633-8","article-title":"Amoxicillin-clavulanate potassium-associated cholestasis","volume":"96","author":"Reddy, R.K.; Brillant, P.; Schiff, E.R.","year":"1989","unstructured":"Reddy RK, Brillant P, Schiff ER. Amoxicillin-clavulanate potassium-associated cholestasis. Gastroenterology 1989; 96: 1135-41.","journal-title":"Gastroenterology"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/0168-8278(89)90061-5","article-title":"Cholestatic hepatitis due to an amoxycillin-clavulanic acid preparation","volume":"9","author":"Verhamme, M.; Ramboer, C.; Van De Bruaene, P.; Inderadjaja, N.","year":"1989","unstructured":"Verhamme M, Ramboer C, Van De Bruaene P, Inderadjaja N. Cholestatic hepatitis due to an amoxycillin-clavulanic acid preparation.J Hepatol 1989; 9: 260-4.","journal-title":"J Hepatol"},{"key":"ref_6","first-page":"355","article-title":"Cholestatic hepatitis after therapy with amoxycillin-clavulanate potassium","volume":"89","author":"Schneider, J.E.; Kleinman, M.S.; Kupiec, J.W.","year":"1989","unstructured":"Schneider JE, Kleinman MS, Kupiec JW. Cholestatic hepatitis after therapy with amoxycillin-clavulanate potassium. NY StateJfMed 1989; 89: 355-6."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1007\/BF01537281","article-title":"Amoxycillin-clavulanic acid (Augmentin) induced intrahepatic cholestasis","volume":"34","author":"Dowsett, J.F.; Gillow, T.; Heagerty, A.; Radcliffe, M.; Toadi, R.; Isle, I.","year":"1989","unstructured":"Dowsett JF, Gillow T, Heagerty A, Radcliffe M, Toadi R, Isle I, et al. Amoxycillin-clavulanic acid (Augmentin) induced intrahepatic cholestasis. Dig Dis Sci 1989; 34: 1290-3.","journal-title":"Dig Dis Sci"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1007\/BF01537113","article-title":"Cholestatic hepatitis due to antibacterial combination of amoxycillin and clavulanic acid (Augmentin)","volume":"34","author":"BHCh, Stricker; JWG, Van Den Broek; J, Keuning; W, Eberhardt; HGJ, Houben; M, Johnson","year":"1989","unstructured":"Stricker BHCh, Van Den Broek JWG, Keuning J, Eberhardt W, Houben HGJ, Johnson M, et al. Cholestatic hepatitis due to antibacterial combination of amoxycillin and clavulanic acid (Augmentin). DigDis Sci 1989; 34: 1576-80.","journal-title":"DigDis Sci"},{"key":"ref_9","first-page":"601","article-title":"Hepatite cholestatique probablement due a I'association d'amoxicilline et d'acide clavulanique","volume":"14","year":"1990","unstructured":"Pelletier G, Ink 0, Fabre M, Hagege H. Hepatite cholestatique probablement due a I'association d'amoxicilline et d'acide clavulanique. Gastroenterol Clin Biol 1990; 14: 601-7.","journal-title":"Gastroenterol Clin Biol"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/0168-8278(90)90230-O","article-title":"Amoxycillin\/ clavulanic acid induced cholestasis","volume":"11","author":"Michielsen, P.P.; Van Outryve, M.J.; Van Marck, E.A.; De Maeyer, M.H.; Pelckmans, P.A.; Van Maercke, Y.M.","year":"1990","unstructured":"Michielsen PP, Van Outryve MJ, Van Marck EA, De Maeyer MH, Pelckmans PA, Van Maercke YM. Amoxycillin\/ clavulanic acid induced cholestasis.J Hepatol 1990; 11: 392.","journal-title":"J Hepatol"},{"key":"ref_11","first-page":"1007","article-title":"Hepatite cholestatique due a I'association amoxicillineacide clavulanique","volume":"14","author":"Cleau, D.; Jobard, J.M.; Alves, T.; Gury, S.; Rey, B.; Vuillemard, M.","year":"1990","unstructured":"Cleau D, Jobard JM, Alves T, Gury S, Rey B, Vuillemard M, et al. Hepatite cholestatique due a I'association amoxicillineacide clavulanique. Gastroenterol Clin Biol 1990; 14: 1007-9.","journal-title":"Gastroenterol Clin Biol"},{"key":"ref_12","first-page":"95","article-title":"Jaundice associated with amoxycillin - clavulanate potassium therapy","volume":"3","author":"Smith, P.M.; Wilton, A.; Routledge, P.A.","year":"1991","unstructured":"Smith PM, Wilton A, Routledge PA. Jaundice associated with amoxycillin - clavulanate potassium therapy. EurJ Gastroenterol Hepatol 1991; 3: 95-6.","journal-title":"EurJ Gastroenterol Hepatol"},{"key":"ref_13","article-title":"Australian Adverse Drug Reactions Bulletin","author":"Jaundice, Augmentin","year":"1990","unstructured":"Augmentin Jaundice. Australian Adverse Drug Reactions Bulletin. November 1990."},{"key":"ref_14","first-page":"137","article-title":"The French system. Drug Safety","volume":"1","author":"Pharmacovigilance, Royer R.J.","year":"1990","unstructured":"Royer RJ. Pharmacovigilance. The French system. Drug Safety 1990; 5 (Suppl 1): 137-40."},{"key":"ref_15","article-title":"Granulomatous hepatitis due to combination of amoxycillin and clavulanc acid","author":"Silvain, C.; Fort, E.; Levillain, P.; Labat-Labourdette, J.; Morichau-Beauchant, M.","year":"1991","unstructured":"Silvain C, Fort E, Levillain P, Labat-Labourdette J, Morichau-Beauchant M. Granulomatous hepatitis due to combination of amoxycillin and clavulanc acid. Dig Dis Sci 1991 (in press).","journal-title":"Dig Dis Sci"},{"key":"ref_16","article-title":"Drug-induced hepatic injury. A comprehensive survey of the literature on adverse drug reactions up toJ7anuary 1985","author":"Stricker, B.H.C.; Spoelstra, P.","year":"1985","unstructured":"Stricker BHC, Spoelstra P. Drug-induced hepatic injury. A comprehensive survey of the literature on adverse drug reactions up toJ7anuary 1985. Elsevier; Amsterdam, 1985."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/0168-8278(90)90124-A","article-title":"Criteria of drug-induced liver disorders. Report of an Intermational consensus meeting","volume":"11","author":"Benichou, C.","year":"1990","unstructured":"Benichou C. Criteria of drug-induced liver disorders. Report of an Intermational consensus meeting. J Hepatol 1990; 11: 272-6.","journal-title":"J Hepatol"},{"key":"ref_18","first-page":"134","article-title":"Beta-lactam antibiotic-induced cholestasis: synergistic of phenobarbitone plus corticosteroid treatment","volume":"20","author":"Trevisani, F.; Panicone, L.; Bernardi, M.; Gasbarrini, Mazzatti M.; G.","year":"1988","unstructured":"Trevisani F, Panicone L, Bernardi M, Mazzatti M. Gasbarrini G. Beta-lactam antibiotic-induced cholestasis: synergistic of phenobarbitone plus corticosteroid treatment. ItalJ Gastroenterol 1988; 20: 134-6.","journal-title":"ItalJ Gastroenterol"},{"key":"ref_19","first-page":"805","article-title":"Ticarcillin-clavulanic acid therapy in severe infections. Drugs Exp Clin","volume":"11","author":"P, Van Der Auwera; JC, Legrand","year":"1985","unstructured":"Van Der Auwera P, Legrand JC. Ticarcillin-clavulanic acid therapy in severe infections. Drugs Exp Clin Res 1985; (Suppl 11): 805-13.","journal-title":"Res"}],"container-title":["Gut"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/gut.33.3.368","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T19:29:22Z","timestamp":1765654162000},"score":1,"resource":{"primary":{"URL":"https:\/\/gut.bmj.com\/lookup\/doi\/10.1136\/gut.33.3.368"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1992,3]]},"references-count":19,"journal-issue":{"issue":"3","published-online":{"date-parts":[[1992,3,1]]},"published-print":{"date-parts":[[1992,3]]}},"alternative-id":["10.1136\/gut.33.3.368"],"URL":"https:\/\/doi.org\/10.1136\/gut.33.3.368","relation":{},"ISSN":["0017-5749","1468-3288"],"issn-type":[{"value":"0017-5749","type":"print"},{"value":"1468-3288","type":"electronic"}],"subject":[],"published":{"date-parts":[[1992,3]]}}}